Time-resolved fluorimetric immunoassay of calprotectin: Technical and clinical aspects in diagnosis of inflammatory bowel diseases

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 3, 2006, Pages 292-298

  Van Der Sluijs Veer, Gertjan ^a   Van Den Hoven, Barbara ^a   Russel, Maurice G V M ^a   Van Den Bergh, Frank A J T M ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Calprotectin; Crohn's disease; Inflammatory bowel disease; Irritable bowel syndrome; Time resolved fluorimetric immunoassay; Ulcerative colitis

Indexed keywords

CALPROTECTIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FLUOROMETRY; GASTROINTESTINAL DISEASE; HUMAN; HUMAN CELL; IMMUNOASSAY; INTESTINAL BLEEDING; INTESTINE TUMOR; IRRITABLE COLON; MAJOR CLINICAL STUDY; NEUTROPHIL CHEMOTAXIS; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOASSAY; INFLAMMATORY BOWEL DISEASES; INTESTINAL NEOPLASMS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33644828250     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.051     Document Type: Article

References (25)

1. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336:763-5.
2. 2+)-dependent translocation from cytoplasm to membranes and cytoskeleton. J Immunol 1996;156:1247-54.
3. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000;43:628-37.
4. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in faeces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.
5. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50-4.
6. Fagerhol MK. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet 2000;356:1783-4.
7. Tibble JA, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47:506-13.
8. Summerton CB, Longlands MG, Wiener K, Shreeve DR. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002;14:823-45.
9. Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, et al. Faecal calprotectin in the assessment of Crohn's disease activity. QJM 2005;98:435-41.
10. Wassell J, Dolwani S, Metzner M, Losty JH, Hawthorne A. Faecal calprotectin: a new marker for Crohn's disease? Ann Clin Biochem 2004;41:230-2.
11. Tøn H, Brandsnes Ø, Dale S, Holtlund J, Skuibina E, Schjønsby H, et al. Improved assay for faecal calprotectin. Clin Chim Acta 2000;292:41-54.
12. Van der Sluijs Veer G, Soons JW. A time-resolved fluoroimmunoassay of the IgM-rheumatoid factor. Eur J Clin Chem Clin Biochem 1992;30:301-5.
13. Hemmilä I. Lanthanides as probes for time-resolved fluorometric immunoassays. Scand J Clin Lab Invest 1998;48:389-400.
14. Hemmilä I. Applications of fluorescence in immunoassays. New York: Wiley-Interscience, 1991.
15. Hemmilä I, Dakabu S, Mukkala V-M, Siitari H, Lövgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984;137:335-43.
16. Hessian PA, Fisher L. The heterodimeric complex of MRP-8 (S100A8) and MRP-14 (S100A9). Antibody recognition, epitope definition and implications for structure. Eur J Biochem 2001;268:353-63.
17. Goebeler M, Roth J, Teigelkamp S, Sorg C. The monoclonal antibody MAC387 detects an epitope on the calcium-binding protein MRP14. J Leukoc Biol 1994;55:259-61.
18. Holtund J, Dale S, Fagerhol MK. Process for the extraction of proteins. PCT International Publication Number WO 98/20355, 14 May 1998.
19. Hanauer SB, Meyers S. Management of Crohn's disease in adults. Am J Gastroenterol 1997;92:559-66.
20. Kristinsson J, Armbruster CH, Ugstad M, Kriwanek S, Nygaard K, Ton H, et al. Faecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics. Scand J Gastroenterol 2001;36:202-7.
21. Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH, et al. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000;46:795-800.
22. Van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I. Calprotectine: een fecale marker voor diagnostiek en follow-up bij patiënten met chronische inflammatoire darmafwijkingen. Ned Tijdschr Geneesk 2003;147:2360-5.
23. Tibbie JA, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut 2001;49:402-8.
24. Tibbie JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
25. Costa F, Mumola MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005;54:364-8.